More on BHC
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $4.93 |
|
|||
| Open | $4.95 | ||||
| 52 Wk High | $4.75 | ||||
| 52 Wk Low | $4.75 | ||||
| Day High | $5.00 | ||||
| Day Low | $4.93 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 168,528 | ||||
- Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States
- Form 4 Bausch Health Companies For: Jul 14 Filed by: LEE STEVEN HYOSIG
- Bausch + Lomb glaucoma eye drop fails Phase 2 trial
- Bausch + Lomb Announces Phase 2 Results for Glaucoma Neuroprotective Candidate
- Bausch + Lomb Introduces Orphia™, an AI-Powered Digital Health Platform Built to Return Physicians to Patient Care
- Bausch Health to Announce Second Quarter 2026 Results on July 29, 2026
- Bausch + Lomb Will Release Second-Quarter 2026 Financial Results on July 29
- Form 4 Bausch Health Companies For: Jun 30 Filed by: WECHSLER AMY B
- Form 4 Bausch Health Companies For: Jun 30 Filed by: Paulson John
- Form 4 Bausch Health Companies For: Jun 30 Filed by: LEUNG SANDRA
Entities mentioned with BHC
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- IPO | View Related Stories »
- Show More...
